Get the Stockscreener App
2.33
5.67%
-0.14
After Hours:
2.20
-0.13
-5.58%
Cyclerion Therapeutics Inc stock is traded at $2.33, with a volume of 70,323.
It is down -5.67% in the last 24 hours and down -1.38% over the past month.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
See More
Previous Close:
$2.47
Open:
$2.47
24h Volume:
70,323
Relative Volume:
0.21
Market Cap:
$7.78M
Revenue:
$556.00K
Net Income/Loss:
$-5.28M
P/E Ratio:
-1.0888
EPS:
-2.14
Net Cash Flow:
$-6.23M
1W Performance:
-6.80%
1M Performance:
-1.38%
6M Performance:
-8.98%
1Y Performance:
-8.81%
1-Day Range:
$2.26
$2.50
1-Week Range:
$2.17
$2.59
52-Week Range:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Name
Cyclerion Therapeutics Inc
Sector
Industry
Phone
617-621-7722
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
2.33 | 7.91M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-21 | Initiated | Truist | Buy |
| Sep-24-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-03-19 | Initiated | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Stock (CYCN) Latest News
Leading vs lagging indicators on Cyclerion Therapeutics Inc. performanceIndex Update & Free Community Supported Trade Ideas - newser.com
Will Cyclerion Therapeutics Inc. stock recover faster than peers2025 Stock Rankings & Daily Stock Momentum Reports - newser.com
Published on: 2025-10-09 06:28:37 - newser.com
Is Cyclerion Therapeutics Inc. stock ready for a breakoutJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-09 05:00:18 - newser.com
Detecting support and resistance levels for Cyclerion Therapeutics Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
Pattern recognition hints at Cyclerion Therapeutics Inc. upsideJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com
What MACD signals say about Cyclerion Therapeutics Inc.July 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Trend Bullish continuation from March 2025Sector-Based Investing & Rapid Portfolio Strategies - earlytimes.in
Best data tools to analyze Cyclerion Therapeutics Inc. stockJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - newser.com
Will Cyclerion Therapeutics Inc. stock recover after recent dropJuly 2025 Technicals & Verified Entry Point Signals - newser.com
Cyclerion Therapeutics Inc. stock volume spike explainedTrade Signal Summary & Short-Term High Return Strategies - newser.com
Will Cyclerion Therapeutics Inc. price bounce be sustainableJobs Report & Short-Term Swing Trade Alerts - newser.com
How to use a screener to detect Cyclerion Therapeutics Inc. breakouts2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
What drives Cyclerion Therapeutics Inc stock pricePortfolio Diversification Tips & Affordable Market Trading - earlytimes.in
Cyclerion Therapeutics Inc Stock Analysis and ForecastStock Price Forecasts & In-Depth Analyst Ratings Explained Simply - Early Times
Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today? - MSN
Real time scanner hits for Cyclerion Therapeutics Inc. explainedInsider Buying & Free Verified High Yield Trade Plans - newser.com
Cyclerion Therapeutics’ Licence Move: Boost or Bust? - StocksToTrade
Hengrui, Glenmark ink ADC deal; Rome Therapeutics to seek ‘strategic options’ - Endpoints News
Why Is Cyclerion Stock Surging In Pre-market Trade? - Nasdaq
Full technical analysis of Cyclerion Therapeutics Inc. stockPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
Cyclerion Therapeutics Inc Stock (CYCN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):